Category: Pharmaceuticals
United States Pharmaceuticals
-
Healthcare Cleanroom Consumables
... at a CAGR of 4.8% over the analysis period 2024-2030. Cleanroom Apparels, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Personal Finance Software
... at a CAGR of 5.0% over the analysis period 2024-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by the end of ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
OTT Devices and Services
... 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Video, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$252.9 Billion by the end ... Read More
-
In-Vitro Fertilization
... CAGR of 8.0% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the analysis period. ... Read More
-
Cycling Power Meters
... at a CAGR of 4.4% over the analysis period 2024-2030. Sports Bicycle, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$300.2 Million by the end of ... Read More
-
Coronary Artery Bypass Grafts (CABG)
... Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Saphenous Vein Grafts, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$164.5 ... Read More
-
Box Office
... CAGR of 15.5% over the analysis period 2024-2030. Action / Adventure, one of the segments analyzed in the report, is expected to record a 17.7% CAGR and reach US$49.0 Billion by the end of the ... Read More
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the analysis period. ... Read More
-
The U.S. Meditation Market
... services, but in-person guidance by trained teachers is still very important. Today, 36 million Americans meditate, fueling a $2.4 billion industry. Like the yoga market, which has seen major growth in the past decade, meditation ... Read More
-
Nail Care
... CAGR of 2.6% over the analysis period 2024-2030. Nail polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Urgent Care Center
... at a CAGR of 6.0% over the analysis period 2024-2030. Trauma / Injury Treatment, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$12.2 Billion by the ... Read More
-
Microgrid as a Service (MaaS)
... Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Grid Connected, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.2 Billion ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Hydroponics
... 14.2% over the analysis period 2024-2030. Tomatoes, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
United States Biosimilars Market Overview, 2030
... because they are typically priced at least 25% lower, providing a means to administer cutting-edge biologic therapy while also managing cost of care. In fact, the US health care system has saved an estimated $23.6 ... Read More
-
Lumpectomy Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
U.S. Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices), By Therapy Area (Stroke, Parkinson’s Disease),- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
... CAGR of 13.2% during the forecast period 2024 to 2033. U.S. Neurorehabilitation Devices Market Key Takeaways: The neurorobotics segment dominated and accounted for the largest revenue share of 36.15% in 2023. The wearable devices segment ... Read More
-
U.S. Compounding Pharmacies Market (By Pharmacy Type: 503A, 503B; By Product: Oral, Liquid Preparations, Topical, Rectal, Ophthalmic, Nasal, Otic; By Sterility: Sterile, Non-Sterile; By Compounding Type: PIA, CUPM, PDA, Others; By Therapeutic Area: Hormone replacement, Pain management, Dermatology, Pediatrics, Urology, Others; By End-User: Hospitals and Clinics, Specialty Clinics, Others) - Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... CAGR of 6.1% from 2024 to 2033. U.S. Compounding Pharmacies Market Key Takeaways By Product, the oral medications segment dominated the market with the largest market share of 36.47% in 2023. By Pharmacy Type, 503A ... Read More
-
U.S. Pharmaceutical CDMO Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034
... CAGR of 7.51% during the forecast period 2024 to 2034. The U.S. pharmaceutical CDMO market growth is driven by rising demand for outsourcing services, increased complexity of drug development processes, and need for cost-effective drug ... Read More
-
U.S. Oncology Molecular Diagnostics Market (By Type: Breast Cancer, Liver Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer, By Technology; PCR, Sequencing, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, TMA, Others; By Product, Reagents, Instruments, Others)) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
... period from 2024 to 2033. U.S. Oncology Molecular Diagnostics Market Key Takeaways By type, the breast cancer segment dominated the market in 2023. By type, the liver cancer segment is expected to grow at a ... Read More
-
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report By Type (SPECT, PET), By PET Product (F-18, SR-82/RB-82), And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
... period from 2024 to 2033. Key Takeaways: The SPECT segment held the largest market share of 61.15% in terms of revenue in 2023 The PET segment is expected to witness a lucrative growth rate of ... Read More
Research Assistance
